Bivalent COVID-19 vaccine boosts immunity but needs to be up

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a Brazilian study reported in the Journal of Medical Virology.

Related Keywords

Bahia , Brazil , China , Barreiras , United States , Wuhan , Hubei , Brazilian , Jaime Henrique Amorim , Souza Ferreira , Covishield Oxford Astrazeneca , Milena Silva Souza , Paulo Biomedical Sciences Institute , University Of Western Bahia , Paulo Research Foundation , Vaccine Development Laboratory , Coronavac Butantan Institute Sinovac , Brazilian Ministry Of Science , Pfizer , Brazilian Ministry , Henrique Amorim , Federal University , Western Bahia , Biomedical Sciences Institute , Carlos De Souza Ferreira , Development Laboratory , Pires Farias , Covid 19 , Vaccine , Antibodies , Ntibody , Coronavirus , Education , Immune Response , Immunity , Influenza , Micron , Pandemic , Research , Research Project , Cars , Ars Cov 2 , Virology , Virus ,